Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
SAMARIUM
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
SAMARIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
42OD65L39F
Molecule Type:
Small molecule
Molecular Formula:
Sm
Molecular Weight:
150.36
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
IROFULVEN
(3)
Small molecule
DNA inhibitor
Unknown
Investigational
Unknown
IROFULVEN
×
Maximum Phase:
3
First Approval:
None
UNII:
6B799IH05A
Molecule Type:
Small molecule
Molecular Formula:
C15H18O3
Molecular Weight:
246.31
AlogP:
1.67
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
1.0
Source:
ZOTAROLIMUS
(3)
Small molecule
FK506-binding protein 1A inhibitor
Unknown
Investigational
Unknown
ZOTAROLIMUS
×
Maximum Phase:
3
First Approval:
None
UNII:
H4GXR80IZE
Molecule Type:
Small molecule
Molecular Formula:
C52H79N5O12
Molecular Weight:
966.23
AlogP:
6.05
PSA:
218.8
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OXETHAZAINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
OXETHAZAINE
×
Maximum Phase:
3
First Approval:
None
UNII:
IP8QT76V17
Molecule Type:
Small molecule
Molecular Formula:
C28H41N3O3
Molecular Weight:
467.65
AlogP:
3.24
PSA:
64.09
HBD:
1.0
HBA:
#RotB:
12.0
Source:
MAGNESIUM
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
MAGNESIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
I38ZP9992A
Molecule Type:
Small molecule
Molecular Formula:
H2Mg
Molecular Weight:
26.32
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
P-TOLUENESULFONAMIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
P-TOLUENESULFONAMIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
I8266RI90M
Molecule Type:
Small molecule
Molecular Formula:
C7H9NO2S
Molecular Weight:
171.22
AlogP:
0.64
PSA:
60.16
HBD:
1.0
HBA:
#RotB:
1.0
Source:
NOLASIBAN
(3)
Small molecule
Oxytocin receptor antagonist
Unknown
Investigational
Unknown
NOLASIBAN
×
Maximum Phase:
3
First Approval:
None
UNII:
3765U8A1EC
Molecule Type:
Small molecule
Molecular Formula:
C20H22N2O3
Molecular Weight:
338.41
AlogP:
2.87
PSA:
62.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BICYCLOL
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
BICYCLOL
×
Maximum Phase:
3
First Approval:
None
UNII:
9734122TH2
Molecule Type:
Small molecule
Molecular Formula:
C19H18O9
Molecular Weight:
390.34
AlogP:
2.11
PSA:
101.91
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RUBIDIUM RB-82
(3)
Small molecule
Diagnostic agent
Unknown
Investigational
Unknown
RUBIDIUM RB-82
×
Maximum Phase:
3
First Approval:
None
UNII:
9K730EL8KU
Molecule Type:
Small molecule
Molecular Formula:
Rb
Molecular Weight:
81.92
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BLARCAMESINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
BLARCAMESINE
×
Maximum Phase:
3
First Approval:
None
UNII:
9T210MMZ3F
Molecule Type:
Small molecule
Molecular Formula:
C19H23NO
Molecular Weight:
281.4
AlogP:
3.53
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FASIGLIFAM
(3)
Small molecule
Free fatty acid receptor 1 positive allosteric modulator
Unknown
Investigational
Unknown
FASIGLIFAM
×
Maximum Phase:
3
First Approval:
None
UNII:
GLP1W4JXAH
Molecule Type:
Small molecule
Molecular Formula:
C29H32O7S
Molecular Weight:
524.64
AlogP:
5.31
PSA:
99.13
HBD:
1.0
HBA:
#RotB:
11.0
Source:
SULFUR HEXAFLUORIDE
(3)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
SULFUR HEXAFLUORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
WS7LR3I1D6
Molecule Type:
Small molecule
Molecular Formula:
F6S
Molecular Weight:
146.06
AlogP:
3.17
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CEBRANOPADOL
(3)
Small molecule
Nociceptin receptor agonist
Unknown
Investigational
Unknown
CEBRANOPADOL
×
Maximum Phase:
3
First Approval:
None
UNII:
7GDW9S3GN3
Molecule Type:
Small molecule
Molecular Formula:
C24H27FN2O
Molecular Weight:
378.49
AlogP:
5.11
PSA:
28.26
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TOZADENANT
(3)
Small molecule
Adenosine A2a receptor antagonist
Unknown
Investigational
Unknown
TOZADENANT
×
Maximum Phase:
3
First Approval:
None
UNII:
D9K857J81I
Molecule Type:
Small molecule
Molecular Formula:
C19H26N4O4S
Molecular Weight:
406.51
AlogP:
2.52
PSA:
87.16
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VELIPARIB
(3)
Small molecule
PARP 1, 2 and 3 inhibitor
Unknown
Investigational
Unknown
VELIPARIB
×
Maximum Phase:
3
First Approval:
None
UNII:
01O4K0631N
Molecule Type:
Small molecule
Molecular Formula:
C13H16N4O
Molecular Weight:
244.3
AlogP:
1.26
PSA:
83.8
HBD:
3.0
HBA:
#RotB:
2.0
Source:
PYROTINIB
(3)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Investigational
Unknown
PYROTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
CJN36EQM0H
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAFAMOSTAT MESYLATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
NAFAMOSTAT MESYLATE
×
Maximum Phase:
3
First Approval:
None
UNII:
1D2T74921W
Molecule Type:
Small molecule
Molecular Formula:
C21H25N5O8S2
Molecular Weight:
539.59
AlogP:
2.65
PSA:
138.07
HBD:
5.0
HBA:
#RotB:
4.0
Source:
TARIBAVIRIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TARIBAVIRIN
×
Maximum Phase:
3
First Approval:
None
UNII:
R3B1994K2E
Molecule Type:
Small molecule
Molecular Formula:
C8H13N5O4
Molecular Weight:
243.22
AlogP:
-2.83
PSA:
150.5
HBD:
5.0
HBA:
#RotB:
3.0
Source:
CENICRIVIROC
(3)
Small molecule
C-C chemokine receptor type 2 antagonist
Unknown
Investigational
Unknown
CENICRIVIROC
×
Maximum Phase:
3
First Approval:
None
UNII:
15C116UA4Y
Molecule Type:
Small molecule
Molecular Formula:
C41H52N4O4S
Molecular Weight:
696.96
AlogP:
8.74
PSA:
85.69
HBD:
1.0
HBA:
#RotB:
17.0
Source:
UNDECANOATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
UNDECANOATE
×
Maximum Phase:
3
First Approval:
None
UNII:
138ON3IIQG
Molecule Type:
Small molecule
Molecular Formula:
C11H22O2
Molecular Weight:
186.29
AlogP:
3.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TEDISAMIL SESQUIFUMARATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TEDISAMIL SESQUIFUMARATE
×
Maximum Phase:
3
First Approval:
None
UNII:
Y4HRG433UU
Molecule Type:
Small molecule
Molecular Formula:
C50H76N4O12
Molecular Weight:
925.17
AlogP:
3.23
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FOSFOMYCIN SODIUM
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
FOSFOMYCIN SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
97MMO19FNO
Molecule Type:
Small molecule
Molecular Formula:
C3H6NaO4P
Molecular Weight:
160.04
AlogP:
-0.09
PSA:
70.06
HBD:
2.0
HBA:
#RotB:
1.0
Source:
M-(18F)-FLUOROBENZYLGUANIDINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
M-(18F)-FLUOROBENZYLGUANIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
CD7WXM716P
Molecule Type:
Small molecule
Molecular Formula:
C8H10FN3
Molecular Weight:
166.19
AlogP:
0.81
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
EDASALONEXENT
(3)
Small molecule
Nuclear factor NF-kappa-B complex inhibitor
Unknown
Investigational
Unknown
EDASALONEXENT
×
Maximum Phase:
3
First Approval:
None
UNII:
AF3Z6434KS
Molecule Type:
Small molecule
Molecular Formula:
C31H42N2O3
Molecular Weight:
490.69
AlogP:
6.72
PSA:
78.43
HBD:
3.0
HBA:
#RotB:
18.0
Source:
MOTEXAFIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
MOTEXAFIN
×
Maximum Phase:
3
First Approval:
None
UNII:
75QG9WGN4U
Molecule Type:
Small molecule
Molecular Formula:
C48H67N5O10
Molecular Weight:
874.09
AlogP:
6.99
PSA:
181.65
HBD:
3.0
HBA:
#RotB:
28.0
Source:
ANDROGRAPHOLIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ANDROGRAPHOLIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
410105JHGR
Molecule Type:
Small molecule
Molecular Formula:
C20H30O5
Molecular Weight:
350.46
AlogP:
1.96
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
OTENABANT
(3)
Small molecule
Cannabinoid CB1 receptor antagonist
Unknown
Investigational
Unknown
OTENABANT
×
Maximum Phase:
3
First Approval:
None
UNII:
J8211Y53EF
Molecule Type:
Small molecule
Molecular Formula:
C25H25Cl2N7O
Molecular Weight:
510.43
AlogP:
4.22
PSA:
101.96
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NICOTINAMIDE RIBOSIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
NICOTINAMIDE RIBOSIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
0I8H2M0L7N
Molecule Type:
Small molecule
Molecular Formula:
C11H15N2O5+
Molecular Weight:
255.25
AlogP:
-2.32
PSA:
116.89
HBD:
4.0
HBA:
#RotB:
3.0
Source:
OLOROFIM
(3)
Small molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial inhibitor
Unknown
Investigational
Unknown
OLOROFIM
×
Maximum Phase:
3
First Approval:
None
UNII:
T34SH2H9HI
Molecule Type:
Small molecule
Molecular Formula:
C28H27FN6O2
Molecular Weight:
498.56
AlogP:
4.08
PSA:
83.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
SIVELESTAT SODIUM
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
SIVELESTAT SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
737RR8Y409
Molecule Type:
Small molecule
Molecular Formula:
C20H29N2NaO11S
Molecular Weight:
528.51
AlogP:
2.25
PSA:
138.87
HBD:
3.0
HBA:
#RotB:
7.0
Source:
ORANTINIB
(3)
Small molecule
Fibroblast growth factor receptor inhibitor
Unknown
Investigational
Unknown
ORANTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
9RL37ZZ665
Molecule Type:
Small molecule
Molecular Formula:
C18H18N2O3
Molecular Weight:
310.35
AlogP:
3.14
PSA:
82.19
HBD:
3.0
HBA:
#RotB:
4.0
Source:
LAQUINIMOD
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
LAQUINIMOD
×
Maximum Phase:
3
First Approval:
None
UNII:
908SY76S4G
Molecule Type:
Small molecule
Molecular Formula:
C19H17ClN2O3
Molecular Weight:
356.81
AlogP:
3.56
PSA:
62.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LOBAPLATIN
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
LOBAPLATIN
×
Maximum Phase:
3
First Approval:
None
UNII:
OX5XK1JD8C
Molecule Type:
Small molecule
Molecular Formula:
C9H18N2O3Pt
Molecular Weight:
397.33
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ASIMADOLINE
(3)
Small molecule
Kappa opioid receptor agonist
Unknown
Investigational
Unknown
ASIMADOLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
D0VK52NV5M
Molecule Type:
Small molecule
Molecular Formula:
C27H30N2O2
Molecular Weight:
414.55
AlogP:
4.08
PSA:
43.78
HBD:
1.0
HBA:
#RotB:
7.0
Source:
VOSAROXIN
(3)
Small molecule
DNA inhibitor
Unknown
Investigational
Unknown
VOSAROXIN
×
Maximum Phase:
3
First Approval:
None
UNII:
K6A90IIZ19
Molecule Type:
Small molecule
Molecular Formula:
C18H19N5O4S
Molecular Weight:
401.45
AlogP:
0.96
PSA:
109.58
HBD:
2.0
HBA:
#RotB:
5.0
Source:
AJMALINE
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
AJMALINE
×
Maximum Phase:
3
First Approval:
None
UNII:
1PON08459R
Molecule Type:
Small molecule
Molecular Formula:
C20H26N2O2
Molecular Weight:
326.44
AlogP:
1.55
PSA:
46.94
HBD:
2.0
HBA:
#RotB:
1.0
Source:
1
2
…
196
197
198
199
200
201
202
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA